411 related articles for article (PubMed ID: 18772312)
1. Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells.
Secchiero P; Melloni E; Corallini F; Beltrami AP; Alviano F; Milani D; D'Aurizio F; di Iasio MG; Cesselli D; Bagnara GP; Zauli G
Stem Cells; 2008 Nov; 26(11):2955-63. PubMed ID: 18772312
[TBL] [Abstract][Full Text] [Related]
2. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
3. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
[TBL] [Abstract][Full Text] [Related]
4. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.
Ponte AL; Marais E; Gallay N; Langonné A; Delorme B; Hérault O; Charbord P; Domenech J
Stem Cells; 2007 Jul; 25(7):1737-45. PubMed ID: 17395768
[TBL] [Abstract][Full Text] [Related]
5. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
6. TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells.
Secchiero P; Zerbinati C; Rimondi E; Corallini F; Milani D; Grill V; Forti G; Capitani S; Zauli G
Cell Mol Life Sci; 2004 Aug; 61(15):1965-74. PubMed ID: 15289937
[TBL] [Abstract][Full Text] [Related]
7. Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing.
Fu X; Han B; Cai S; Lei Y; Sun T; Sheng Z
Wound Repair Regen; 2009; 17(2):185-91. PubMed ID: 19320886
[TBL] [Abstract][Full Text] [Related]
8. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways.
Ryu CH; Park SA; Kim SM; Lim JY; Jeong CH; Jun JA; Oh JH; Park SH; Oh WI; Jeun SS
Biochem Biophys Res Commun; 2010 Jul; 398(1):105-10. PubMed ID: 20558135
[TBL] [Abstract][Full Text] [Related]
9. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.
Grisendi G; Bussolari R; Cafarelli L; Petak I; Rasini V; Veronesi E; De Santis G; Spano C; Tagliazzucchi M; Barti-Juhasz H; Scarabelli L; Bambi F; Frassoldati A; Rossi G; Casali C; Morandi U; Horwitz EM; Paolucci P; Conte P; Dominici M
Cancer Res; 2010 May; 70(9):3718-29. PubMed ID: 20388793
[TBL] [Abstract][Full Text] [Related]
10. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.
Belyanskaya LL; Ziogas A; Hopkins-Donaldson S; Kurtz S; Simon HU; Stahel R; Zangemeister-Wittke U
Lung Cancer; 2008 Jun; 60(3):355-65. PubMed ID: 18093694
[TBL] [Abstract][Full Text] [Related]
11. Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis.
Secchiero P; Zauli G
Curr Opin Hematol; 2008 Jan; 15(1):42-8. PubMed ID: 18043245
[TBL] [Abstract][Full Text] [Related]
12. Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells.
Corallini F; Celeghini C; Rimondi E; di Iasio MG; Gonelli A; Secchiero P; Zauli G
J Cell Physiol; 2011 Sep; 226(9):2279-86. PubMed ID: 21660951
[TBL] [Abstract][Full Text] [Related]
13. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells.
Boland GM; Perkins G; Hall DJ; Tuan RS
J Cell Biochem; 2004 Dec; 93(6):1210-30. PubMed ID: 15486964
[TBL] [Abstract][Full Text] [Related]
14. Fetal-derived trophoblast use the apoptotic cytokine tumor necrosis factor-alpha-related apoptosis-inducing ligand to induce smooth muscle cell death.
Keogh RJ; Harris LK; Freeman A; Baker PN; Aplin JD; Whitley GS; Cartwright JE
Circ Res; 2007 Mar; 100(6):834-41. PubMed ID: 17322170
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL).
Zauli G; Rimondi E; Celeghini C; Milani D; Secchiero P
J Cell Physiol; 2010 Feb; 222(2):357-64. PubMed ID: 19877156
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand.
Secchiero P; Gonelli A; Carnevale E; Corallini F; Rizzardi C; Zacchigna S; Melato M; Zauli G
Neoplasia; 2004; 6(4):364-73. PubMed ID: 15256058
[TBL] [Abstract][Full Text] [Related]
18. The pleiotropic effect of TRAIL on tumor-like synovial fibroblasts from rheumatoid arthritis patients is mediated by caspases.
Audo R; Combe B; Coulet B; Morel J; Hahne M
Cell Death Differ; 2009 Sep; 16(9):1227-37. PubMed ID: 19407827
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells.
Tamama K; Fan VH; Griffith LG; Blair HC; Wells A
Stem Cells; 2006 Mar; 24(3):686-95. PubMed ID: 16150920
[TBL] [Abstract][Full Text] [Related]
20. TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.
Manzo F; Nebbioso A; Miceli M; Conte M; De Bellis F; Carafa V; Franci G; Tambaro FP; Altucci L
Int J Biochem Cell Biol; 2009 Mar; 41(3):460-6. PubMed ID: 18243765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
